Clinical trials
Completed Neuromuscular Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 4 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 61 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 7 |
| Columbia University | 5 |
| Catabasis Pharmaceuticals | 2 |
| Craig McDonald, MD | 2 |
| Emory University | 2 |
| Intermountain Health Care, Inc. | 2 |
| NMD Pharma A/S | 2 |
| National Institute of Nursing Research (NINR) | 2 |
| PTC Therapeutics | 2 |
| Scholar Rock, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuromuscular Diseases | 61 |
| Nervous System Diseases | 16 |
| Muscular Diseases | 15 |
| Muscular Dystrophies | 13 |
| Musculoskeletal Diseases | 13 |
| Muscular Dystrophy, Duchenne | 11 |
| Amyotrophic Lateral Sclerosis | 10 |
| Muscular Atrophy, Spinal | 10 |
| Genetic Diseases, Inborn | 8 |
| Motor Neuron Disease | 7 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.